| Price | 16.50p on 19-02-2026 at 04:45:18 |
|---|---|
| Change | 0.00p 0% |
| Buy | 17.00p |
| Sell | 16.00p |
| Last Trade: | Sell 3,000.00 at 16.45p |
| Day's Volume: | 0 |
| Last Close: | 16.50p |
| Open: | 17.00p |
| ISIN: | GB00BMC3RJ87 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 9.00p - 28.00p |
| Market Capitalisation: | £22.78m |
| VWAP: | 0.00p |
| Shares in Issue: | 138.07m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Sareum (SAR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 3,000 | 16.45p | Ordinary |
16:28:57 - 18-Feb-26 |
| Buy* | 34 | 17.00p | Ordinary |
16:26:37 - 18-Feb-26 |
| Buy* | 34 | 17.00p | SI Trade |
16:26:37 - 18-Feb-26 |
| Sell* | 18,772 | 16.03p | Ordinary |
16:26:21 - 18-Feb-26 |
| Unknown* | 3,000 | 16.50p | Ordinary |
16:12:51 - 18-Feb-26 |
| Buy* | 529 | 17.00p | Ordinary |
15:41:32 - 18-Feb-26 |
| Buy* | 34 | 17.00p | Ordinary |
15:40:44 - 18-Feb-26 |
| Buy* | 34 | 17.00p | SI Trade |
15:40:44 - 18-Feb-26 |
| Sell* | 8,172 | 16.25p | Ordinary |
15:21:31 - 18-Feb-26 |
| Buy* | 1,126 | 16.60p | Ordinary |
14:52:35 - 18-Feb-26 |
Sareum (SAR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 17th Feb 2026 7:00 am | RNS | Restart of Phase 2-enabling toxicology programme |
| 23rd Jan 2026 4:36 pm | RNS | Form 8.3 - Oxford Biomedica plc |
| 9th Dec 2025 4:25 pm | RNS | Results of AGM |
| 9th Dec 2025 7:00 am | RNS | Annual General Meeting Statement |
| 17th Nov 2025 7:00 am | RNS | Notice of AGM, Annual Report and Accounts |
| 30th Oct 2025 7:00 am | RNS | Appointment of Joint Corporate Broker |
| 23rd Oct 2025 7:00 am | RNS | Preliminary Results for Year Ended 30 June 2025 |
| 10th Oct 2025 7:00 am | RNS | Update on toxicology study for SDC-1801 |
| 7th Oct 2025 7:00 am | RNS | Notice of Results and Investor Presentation |
| 26th Sep 2025 3:12 pm | RNS | Exercise of Warrants |
